Clinical Trial Update: BRIEF-PCI: Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating a brief infusion of eptifibatide after percutaneous coronary intervention (PCI) in patients with coronary artery disease or myoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Infarction

Drugs mentioned

• EPTIFIBATIDE (EPTIFIBATIDE)

Snippet

Sponsor: Cardiology Research UBC | Conditions: Coronary Artery Disease, Myocardial Infarction | Phase 4 | Status: COMPLETED